DEA Audit and DEA Investigations
Federal Health Care Fraud Defense Attorneys for Drug Enforcement Administration (DEA) Matters
The Drug Enforcement Administration (DEA) is among the numerous federal agencies involved in regulating the health care market and with responsibility for investigating and prosecuting cases of suspected health care fraud. Within the health care industry, the DEA’s primary focus is on the prescription, distribution, and administration of prescription medications, and its authority extends over physicians, pharmacists, clinics, hospitals, hospices, and other providers who deal in controlled prescription drugs.
The Help You Need to Deal with the DEA Investigations
Oberheiden & McMurrey LLP is a national health care fraud defense law firm that represents clients in DEA audits, DEA investigations, and other federal matters. Our team includes nationally-recognized defense lawyers and former federal prosecutors who have successfully represented clients in a broad array of cases, including cases involving allegations ranging from Medicare and Tricare billing violations to the illegal distribution of prescription medications. Regardless of the specific issue at hand, any matter involving the DEA investigations needs to be taken extremely seriously, as the potential penalties for prescription-related health care offenses can include exorbitant fines and years in federal prison. In many cases, DEA investigations will lead to multiple counts of alleged civil or criminal offenses, leading to multi-million-dollar exposure and the potential for an effective life sentence.
The DEA regulates all health care providers whose practices involve prescription medications, and all companies and practitioners that deal with prescription medications must have a DEA Certificate of Registration. Registration with the DEA is not automatic, and DEA registrations can be revoked. In addition to representing DEA registrants in civil and criminal enforcement matters, we also routinely assist clients with issues pertaining to DEA registration and renewal.
“I’m not typically one to post reviews but felt my experience needed to be heard publicly. [Oberheiden & McMurrey LLP] is unlike your stereotypical law firm. Their level of professionalism, dedication and sensitivity to me and my situation made me feel comfortable and confident I was in the right hands. Hopefully I won’t find myself in a situation where I’d need law services again[,] but if I did they would be the first I’d call.” – Satisfied Client
“I hired Nick Oberheiden and [Oberheiden & McMurrey LLP] to defend me in a criminal healthcare matter. From the first moment I met with Nick[,] I knew that he [would] get me the help I need[ed]. . . . No charges. Case Dismissed.” – Satisfied Client
Experienced Representation for All Health Care-Related DEA Matters
Our DEA defense attorneys and former federal prosecutors represent DEA registrants and other health care providers nationwide in all DEA-related matters. The scope of our DEA practice includes:
The DEA routinely audits registered health care providers for compliance with the Controlled Substances Act (CSA) and various other federal laws and regulations. Although many of these DEA audits are conducted at random, the DEA can also inquire into a provider’s business or practice as a result of a tip received from a patient or other provider (such as a pharmacist concerned about a doctor’s prescription practices), or as a result of “anomalies” in a provider’s prescription rates and federal benefit program billing practices.
If you have received a DEA Form 82 (Notice of Inspection of Controlled Premises) or an administrative inspection warrant, it is imperative that you seek legal representation promptly. Providers have important rights during DEA audits and inspections, and you need to try to make sure that the DEA’s inquiry does not lead to further government investigation.
DEA agents work closely with prosecutors at the U.S. Department of Justice (DOJ) and other agencies to prosecute health care providers suspected of fraud and other crimes involving the prescription, distribution, and administration of prescription drugs. When you are going through a DEA audit and investigation and defending against these types of allegations, it is critical to have legal representatives with a thorough understanding of Current Procedural Terminology (CPT) and ICD9/ICD10 coding guidelines, as lawyers without adequate knowledge of the health care billing system for federal program participants will need to spend time getting up to speed before they can begin building a strategic defense. At Oberheiden & McMurrey LLP, all of our health care fraud defense attorneys have extensive knowledge of the applicable medical and legal policies and procedures, and we are able to hit the ground running to quickly protect our clients in criminal DEA enforcement matters.
Disciplinary actions stemming from DEA audits and investigations can lead to consequences including loss of licensure, loss of DEA registration, and the potential for additional penalties resulting from a civil or criminal enforcement proceeding. We represent clients facing disciplinary action as a result of DEA investigations involving allegations of prescription drug diversion, unlawful distribution of controlled substances, failure to keep necessary records, prescription labeling violations, and all other forms of prescription drug fraud.
All physicians, pharmacists, dentists, nurse practitioners, and other medical professionals who prescribe, dispense, and administer prescription medications are subject to mandatory registration with the DEA. DEA registration can be a lengthy and difficult process, and facing a denial of registration or renewal can obviously have severe consequences for providers in all branches of the health care industry.
Before denying registration, the DEA must issue an order to show cause. It must also grant a hearing if you request one. Responding to a show cause order and appearing at DEA registration denial hearings are complicated procedures that should be handled by an experienced DEA defense attorney.
When DEA agents target practitioners in audits and investigations, they will often seek to have providers voluntarily surrender their DEA registrations. You are not required to surrender your registration at this time, and it is critical that you take appropriate steps to protect your rights – including your right to practice. If you have been contacted by the DEA and asked to surrender your registration, you need to seek legal representation as soon as possible. If you have already surrendered your registration, you will need your lawyers to work with the DEA in order to mitigate any potential consequences of the surrender.
While the DEA can seek to suspend or revoke a provider’s registration for a number of reasons, its power to suspend and revoke registrations is not absolute – and providers must act carefully in order to avoid wrongful interference with their ability to prescribe, dispense, and administer prescription medications. Whether you have just received a show cause order or your DEA registration has already been suspended or revoked, our DEA audit attorneys can execute a comprehensive defense strategy designed to protect your right to practice.
FAQs: The DEA and Health Care Fraud Enforcement
Q: Is it true that the DEA must obtain a provider’s informed consent before conducting an audit?
In most cases, yes. When the DEA seeks to obtain information about a health care provider pursuant to a DEA Form 82, it must obtain the provider’s informed consent prior to initiating the audit. However, the DEA is not required to obtain the provider’s informed consent in the following scenarios.
- The audit is of a provider applying for its initial DEA registration.
- The audit is being performed pursuant to an administrative subpoena.
- The audit is being conducted due to a threat of “imminent danger” to public health or safety and there is not sufficient time to obtain a warrant.
In all other cases, unless a specific exception applies, the DEA must obtain informed consent or an administrative inspection warrant prior to inspecting a health care provider’s books and records.
Q: Should I refuse to give informed consent to a DEA audit?
This is a question that requires individual and case-specific legal advice, so you will need to discuss your situation with a DEA defense lawyer. What we can tell you, however, is that you have every right to seek legal representation when the DEA contacts you, and this includes the right to seek legal advice about the DEA’s request for informed consent.
Q: Can I lose my medical license as a result of a DEA audit, inspection, or investigation?
Potentially, yes. Since medical licensure is a matter of state law and the standards for maintaining a medical license vary from those for civil or criminal liability under federal health care law, it is possible that a provider could lose their license as a result of a DEA inquiry even if the inquiry does not ultimately lead to federal charges. And if you are convicted, this can trigger an automatic suspension or revocation of your license.
The licensing implications of a DEA audit, inspection, or investigation are among the numerous collateral effects of being targeted for federal enforcement – and are among the numerous reasons why providers who are in the DEA’s crosshairs must choose experienced legal representation.
Q: What are some common allegations in DEA criminal and civil enforcement matters?
The DEA investigates a wide range of prescription-related health care law offenses. DEA registrants targeted in these investigations are commonly being suspected or accused of:
- Compound pharmacy fraud
- Conspiracy to possess and dispense controlled prescription medications
- Dispensing prescription medications without proper labeling
- Dispensing or prescribing medications outside of the scope of professional practice
- Failure to keep appropriate records
- Falsifying prescriptions and patient records
- Offering or accepting illegal kickbacks in exchange for patient referrals
- Prescribing controlled substances without medical necessity or without performing an in-person exam
- Prescribing or dispensing medications to someone who is drug-dependent
- Prescription drug diversion
- Unlawful distribution of prescription medications
- Upcoding, double-billing, and other forms of billing fraud
Q: On what grounds can the DEA legally deny registration to a provider who seeks to prescribe, dispense, or administer controlled substance medications?
There are five statutory bases on which the DEA can lawfully deny registration to a health care provider seeking to prescribe, dispense, or administer controlled substance medications. These are:
- Supplying false information on a registration application
- Prior felony conviction
- Prior denial, suspension, or revocation of a state license or registration
- Exclusion from Medicare, Medicaid, Tricare, or another federal health care benefit program
- Engaging in acts that the DEA considers to be “inconsistent with the public interest”
Q: What does it mean if the DEA has denied my registration application on the basis that registration would be “inconsistent with the public interest”?
If the DEA has denied your registration on the basis that registration would be “inconsistent with the public interest,” this means that the DEA believes one or more of the factors below.
- You have ineffective controls against the diversion of controlled prescription medications.
- You have failed to comply with state or local law.
- You have a prior state or federal conviction involving the manufacture, dispensing, or distribution of controlled substances.
- You lack experience in the distribution of controlled substances.
- There are other factors that apply in your case which make registration dangerous to public health and safety.
Meet Our Team of DEA Defense Lawyers
Dr. Nick Oberheiden
Dr. Nick Oberheiden is a federal health care fraud defense attorney who has extensive experience representing providers in a wide range of DEA-related matters, such as DEA audits and DEA investigations. As the firm’s founder and Principal Partner, Dr. Oberheiden is personally involved in all healthcare-related matters, and he offers a wealth of insights for defending registered and non-registered providers in DEA audits and investigations.
William (Bill) C. McMurrey
William (Bill) C. McMurrey is a former prosecutor with the DOJ responsible for handling health care fraud enforcement matters. With nearly 30 years of legal experience, Mr. McMurrey is a trusted advocate and go-to resource for providers across the country who are being targeted by the DEA.
Lynette S. Byrd
Lynette S. Byrd is a former DOJ prosecutor who handled dozens of high-profile health care fraud investigations during her tenure with the federal government. In private practice, Ms. Byrd works closely with her clients to develop and execute comprehensive defense strategies for DEA audits and investigations.
Glenn A. Harrison
Glenn A. Harrison is a former DOJ prosecutor and Special Assistant U.S. Attorney who has decades of experience in complex health care fraud matters involving the DEA and numerous other federal agencies. An experienced litigator, much of Mr. Harrison’s practice is devoted to representing clients in civil and criminal health care fraud enforcement matters.
Do You Have a Question About Any DEA Matter? Schedule a Free and Confidential Consultation at Oberheiden & McMurrey LLP
If you need help for any issue involving the DEA, we encourage you to contact us promptly to arrange a free and confidential consultation. To speak with the DEA defense lawyers at Oberheiden & McMurrey LLP, please call (888) 452-2503 or submit your information online today.